Elective Colectomy
Treatment for Diverticulitis
Typical Dosage: N/A
Effectiveness
95%
Safety Score
50%
Clinical Trials
5
Participants
15K
Comparative Safety Scale(Higher is safer)
Cyanideβ οΈ
Methπ
Cigarettesπ¬
Chemoβ’οΈ
AlcoholπΊ
Morphineπ
Antibioticsπ
Tylenolπ
Exerciseπ
Waterπ§
50
DangerousModerateSafe
Treatment Details
Dosage Range
N/A
Time to Effect
Immediate prevention (recovery 4-8 weeks)
Treatment Duration
One-time procedure
Evidence Quality
MODERATENumber Needed to Treat (NNT)
3(Treat 3 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
15(Treat 15 patients to see 1 additional serious adverse event)
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$2,500
Side Effect Mgmt:$500
Total Annual:$3,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOODICER
$55,000/QALY
QALYs Gained
0.8
Outcome-Based Costs
Cost per Responder
$3,158
Comparison vs Long-term conservative management for recurrent diverticulitis
Cost Difference
+$2,500/year
More expensive
QALY Difference
+0.60 QALYs
Better outcomes
Dominance
No dominance
Elective Colectomy Outcomes
for Diverticulitis
Efficacy Outcomes
Overall Effectiveness
+95%
Response Rate
+95%
Common Side Effects
Surgical site infection
+10%
Anastomotic leak
+2%
Post-operative ileus
+7%
Hernia (long-term)
+8%
Changes in bowel habits
+30%
Sources:
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
2 active trials recruiting for Elective Colectomy in Diverticulitis
Comparison of Surgery and Medicine on the Impact of Diverticulitis (COSMID) Trial
NCT04095663ACTIVE NOT RECRUITINGNA
255 participants
INTERVENTIONAL
Los Angeles, United States +28 more
Started: Oct 1, 2019
Surgical Site Infection Outcomes in Natural Orifice Intracorporeal Anastomosis and Extraction (NICE) Procedure - The NICE Trial
NCT06957236ENROLLING BY INVITATION
300 participants
OBSERVATIONAL
Houston, United States
Started: Apr 2, 2025